ONCS Stock UPDATES Oncosec Medical Inc (ONCS) 0.5310 09/11/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 11, 2014 at 3:52 AM

Oncosec Medical Inc (ONCS) 0.5310 $ONCS

OncoSec Medical to Present Data at ESMO 2014 Congress
Business Wire - Tue Sep 09, 5:02AM CDT
OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, will present data from ongoing clinical and pre-clinical studies at the European Society for Medical Oncology (ESMO) 2014 Congress, to be held September 26-30 in Madrid, Spain. OncoSec is proud to be presenting an abstract titled, "Immune correlates of intratumoral IL-12 electroporation", as part of a poster presentation taking place 12:45 PM - 1:45 PM CEST on Sunday, September 28th.

OTC Daily News Report
PR Newswire Europe - Wed Sep 03, 8:05AM CDT
LONDON, September 3, 2014 /PRNewswire/ --

OncoSec Medical to Present at Five Events in September
Business Wire - Tue Sep 02, 5:02AM CDT
OncoSec Medical Inc. (OTCQB:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, will present at five events in September. The company's agenda includes a number of high-profile scientific and investment conferences.

OTC Daily Stock News: Apptigo International, Inc. Onco Sec Medical Inc., Monitise PLC, American Green, Inc. Terra Tech Corp, MusclePharm Corp
PR Newswire Europe - Thu Aug 07, 7:02AM CDT
LONDON, August 7, 2014 /PRNewswire/ --

OncoSec Medical names Dr Holbrook Kohrt to SAB
M2 - Wed Aug 06, 6:19AM CDT
Biopharmaceutical company OncoSec Medical (OTCQB:ONCS) disclosed on Wednesday that Dr Holbrook Kohrt, MD, PhD has been elected to its Scientific Advisory Board.

OncoSec Medical Appoints Dr. Holbrook Kohrt to Scientific Advisory Board
Business Wire - Wed Aug 06, 5:02AM CDT
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based intratumoral cancer immunotherapy, has appointed Dr. Holbrook Kohrt, M.D., Ph.D., to the company's Scientific Advisory Board. Dr. Kohrt joins a growing panel of distinguished experts and renowned thought leaders, and will contribute his considerable expertise to the company as it works to advance an expanding immuno-oncology pipeline.

OncoSec Medical To Present at 2014 DNA Vaccine Conference
Business Wire - Thu Jul 17, 5:02AM CDT
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based intratumoral cancer immunotherapy, announces that several company representatives will present at the International Society of DNA Vaccines (ISDV) 2014 DNA Vaccine Conference, being held July 21-23, 2014 at the Westin San Diego Gaslamp Quarter Hotel in San Diego, CA.

OncoSec Medical To Present at Bioelectrochemistry Gordon Research Conference on July 8 and July 10
Business Wire - Wed Jul 02, 5:02AM CDT
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based intratumoral cancer immunotherapy, announces that Robert Pierce, M.D., Chief Medical Officer, and Richard Heller, Ph.D., Scientific Advisory Board member, will present at the Bioelectrochemistry Gordon Research Conference being held July 6-11, 2014 at the University of New England in Biddeford, ME.

OncoSec Medical Appoints Dr. Soldano Ferrone to Scientific Advisory Board
Business Wire - Wed Jun 25, 5:02AM CDT
OncoSec Medical Inc. (OTCQB:ONCS), a company developing its ImmunoPulse DNA-based intratumoral cancer immunotherapy, has appointed Dr. Soldano Ferrone, M.D., Ph.D., to the company's Scientific Advisory Board. Dr. Ferrone is an internationally renowned expert in tumor immunology, and will contribute his considerable expertise to the company as it works to advance an expanding intratumoral immunotherapy pipeline.

OncoSec Medical Announces YTD Results as of April 30, 2014
Business Wire - Fri Jun 13, 8:00AM CDT
OncoSec Medical Inc. (OTCQB:ONCS), a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, today announced financial results for the nine months ended April 30, 2014.

OncoSec Medical Issues Annual Letter To Shareholders
Business Wire - Thu Jun 12, 5:03AM CDT
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based intratumoral cancer immunotherapy, today issued the following letter from Punit Dhillon, President and CEO, to the company's shareholders:

OncoSec Medical to Present at Two Conferences in New York City in April
Business Wire - Mon Mar 31, 5:03AM CDT
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will present at the 13th Annual Needham Healthcare Conference and the HemOnc Today Melanoma and Cutaneous Malignancies Meeting in April.

PUNIT DHILLON of OncoSec Medical Incorporated (ONCS)-Other O bought Shares of ONCS
M2 - Fri Mar 21, 7:39AM CDT
Reported by InsiderCow.com at 2014-03-20 14:21:26 ET

OncoSec Medical to Present at 2nd Annual Sachs Cancer Bio Partnering & Investment Forum
Business Wire - Mon Mar 17, 5:03AM CDT
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid tumors, today announced that Punit Dhillon, President and CEO, will present a corporate overview of the company at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum at the New York Academy of Sciences on Wednesday, March 19th at 3:00 p.m. (EST).

OncoSec Medical to Evaluate Increased Dose Frequency of ImmunoPulse in Ongoing Phase II Melanoma Trial
Business Wire - Wed Mar 12, 5:02AM CDT
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid tumors, announced today that the company has submitted a protocol addendum to the FDA and institutional IRBs to evaluate an increased dose frequency for ImmunoPulse in an expansion of its ongoing Phase II melanoma trial. The Company expects to enroll up to 21 patients in this expansion, and expects two additional key cancer centers as sites participating in this study.

OncoSec Medical to Present at 24th Annual Wall Street Analyst Forum Institutional Investor Conference
Business Wire - Tue Feb 25, 5:02AM CST
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid tumors, today announced that Punit Dhillon, President and CEO, will present a corporate overview of the company at the 24th Annual Wall Street Analyst Forum Institutional Investor Conference at the University Club in New York, New York on Monday, March 3rd at 12:05 p.m. (EST).

OTC Daily Alert Stock Watch - OncoSec Medical Incorporated (OTCQB: ONCS)
WorldStockWire - Thu Feb 06, 2:45PM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

OncoSec Medical to Present at 16th Annual BIO CEO & Investor Conference
Business Wire - Tue Feb 04, 5:02AM CST
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid tumors, today announced that Punit Dhillon, President and CEO, will present a corporate overview of the company at the 16th Annual BIO CEO & Investor Conference at the Waldorf Astoria in New York, New York on Monday, February 10 at 4:00 p.m. (EST) in the third floor Basildon Suite.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rural Hospitals Face Shaky Future; Warbird RCM Steps In

Revamping Revenue Cycle Management for Rural Healthcare In a world that's increasingly teetering on the delicate tightrope of balance sheets, Warbird Healthcare Advisors is stepping into the ring with fists up, ready to fight for rural hospitals. Introducing their latest venture, Warbird RCM Partners, they're honing in on revenue cycle management and billing services to...

TLC Jet Teams Up with WIMCO St. Barth Properties

Setting the Jet Set Stage Aflame In the ever-glam world of high-end travel, TLC Jet, out of Fort Lauderdale, has just inked a deal with WIMCO St. Barth Properties. Look, if you've got a penchant for island hopping or sipping your cocktail with sand between your toes, this aligns perfectly with your luxury cravings. This duo isn't just whispering sweet nothings in the...

Panasonic's Astrova Hits 500,000 Sales Mark Milestone

Astrova's Explosive Growth in the IFEC Market When you hear about Panasonic Avionics smashing the half-million mark with their Astrova screens, you sit up and take notice. Not every day you see in-flight entertainment (IFE) tech climbing the adoption charts this fast. It's a testament not just to the gadget itself but also to how airlines are jumping on board to give...

Beyond The Bounce Expands with Pro Pickleball Star

Pickleball's Power Play: The Media Move Out of the blue, the world of niche sports finds its hub. Beyond The Bounce steps up to the plate by roping in pickleball’s own Zane Navratil. The hype’s not in the spin here—this is serious business. The company plans to push the boundaries of the sport into mainstream media, or at least give it a decent shot. Zane Navratil:...

JJ Lin's Iconic Singapore Grand Prix Show With 20 Songs

Nothing beats the thrill of a live performance under a night sky, with the adrenaline of a Formula 1 race still in the air. On October 9, 2026, Mandopop superstar JJ Lin captivated the crowd at the Padang Stage of the Singapore Grand Prix, delivering not just a concert but a spectacle of international scale. Stage Spectacle with Precision JJ Lin took control like a...

Monterey Desalination Project: Costs, Challenges & Future

Water Woes Dragging on in Monterey? Alright, let's dive into the nitty-gritty of this water supply saga in the Monterey Peninsula. If you're wondering why California American Water is hustling so hard, it's because the taps around here ain't running like they should. This mess has been stretching on for ages, with everyone thirsty for a sustainable answer. The Cost of...

Dimora Medical Boosts Advanced Wound Care at HS Conference

Empowering the HS Community with Innovations Look, if you’ve walked a mile in someone else's shoes—particularly ones dealing with hidradenitis suppurativa (HS)—you’d know what a relentless grind managing those exuding wounds can be. Dimora Medical, known for navigating the tricky territory of wound care, threw its hat into the ring at the HS Connect Empower...

Iowa Voters Strongly Favor Funding Water Quality Trust

A Growing Concerns in Iowa From the heart of Iowa comes a noise that state leaders better not ignore. Water quality—something folks maybe dismissed as a bureaucratic afterthought in the past—is now screaming from every corner of Iowa's farmland and urban landscapes. You'd barely bat an eye in Iowa now without hearing someone fretting over murky streams or unsafe...

ZPMC's Wind Power and Port Projects Earn Top Honors

Wind Farms and Ports: A Winning Formula National applause rings out for Shanghai Zhenhua Heavy Industries Co., Ltd. (ZPMC) as they snagged top honors in the recent National Quality Engineering Awards. It's about time folks recognized the heavy lifting these projects do in reshaping our energy and port infrastructure. Two of their standout projects walked away with...

Civista Welcomes Healthcare Leader to Boost Growth

Expanding the Boardroom with Healthcare Expertise In an unexpected twist for Civista Bancshares (NASDAQ: CIVB), the financial holding company is roping in some healthcare brass to its board. Jeremy Normington-Slay just snagged a seat at Civista's table, and he's bringing his tough-sledding healthcare leadership chops straight from Firelands Health. A $4.3 billion outfit...